Skip to main content

Table 1 Patients characteristics and renal findings on biopsy

From: Renal AA-amyloidosis in intravenous drug users – a role for HIV-infection?

Age (years)

41 (33 – 46)

Male – n (%)

15 (62.5%)

Self-reported time after initiation of IVDU (years)

22 (13 – 30)

Self-reported duration of IVDU in years

17 (8 – 25)

History of opioid maintenance therapy

12 (50%)

Chronic hepatitis B

1 (4.2%)

Past HBV exposure

7 (29.2%)

Chronic hepatitis C

21 (87.5%)

HIV infection

10 (41.7%)

Renal disease by biopsy-findings – n (%)

 

 AA-amyloidosis

12 (50.0%)

 Membranoproliferative GN Type I

5 (20.8)

 Nephrosclerosis

2 (8.3%)

 Extracapillary proliferative GN

2 (8.3%)

 Focal segmental Glomerulosclerosis

1 (4.2%)

 Chronic tubulointerstitial nephritis

1 (4.2%)

 Lupus nephritis Class IV

1 (4.2%)

  1. Variables are expressed as median and interquartile-range (IQR) or as proportions as appropriate.